TRELLUS HEALTH PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.65 GBX | 0.00% |
|
0.00% | -49.23% |
| Apr. 24 | Transcript : Trellus Health plc, Q4 2023 Earnings Call, Apr 24, 2024 | |
| Apr. 23 | EARNINGS: Videndum warns on recovery; AB Dynamics expects profit beat | AN |
Financials (USD)
| Sales 2021 | 0.02 | Sales 2022 | 0.02 | Capitalization | 19.53M |
|---|---|---|---|---|---|
| Net income 2021 | -5M | Net income 2022 | -8M | EV / Sales 2021 | 2,872,307,841 x |
| Net cash position 2021 | 31.98M | Net cash position 2022 | 19.08M | EV / Sales 2022 | 24,968,473 x |
| P/E ratio 2021 |
-14.3
x | P/E ratio 2022 |
-2.22
x | Employees | 31 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 53.61% |
More Fundamentals
* Assessed data
More news
Latest transcript on Trellus Health plc
More press releases
| Current month | -13.16% | ||
| 1 month | -17.50% | ||
| 3 months | -56.00% | ||
| 6 months | -63.33% | ||
| Current year | -49.23% |
1 week
1.50
1.80
1 month
1.502.50
Current year
1.507.38
1 year
1.509.65
3 years
1.5078.00
5 years
1.5078.00
10 years
1.5078.00
| Managers | Title | Age | Since |
|---|---|---|---|
Marla Dubinsky
FOU | Founder | - | 20-07-14 |
Joy Bessenger
DFI | Director of Finance/CFO | - | 23-09-17 |
Alex Lorenzo
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Daniel Mahony
CHM | Chairman | - | - |
Erik Lium
BRD | Director/Board Member | 56 | - |
Marla Dubinsky
FOU | Founder | - | 20-07-14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 1.65 | 0.00% | 1,247,954 |
| 24-05-23 | 1.65 | 0.00% | 50,310 |
| 24-05-22 | 1.65 | 0.00% | 44,282 |
| 24-05-21 | 1.65 | 0.00% | 20,000 |
| 24-05-20 | 1.65 | 0.00% | 0 |
Delayed Quote London S.E., May 24, 2024 at 11:35 am EDT
More quotes
Trellus Health plc is a United Kingdom-based health services company, which is engaged in providing solutions and services for chronic condition management. The Company is focused on chronic costly GI conditions that have high mental health burden, such as inflammatory bowel disease (IBD) which includes the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The Company has one division being the providing resilience-driven care for chronic conditions in the inflammatory bowel disease state. The Companyâs Trellus Elevate platform is a connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Trellus Elevateâs personalized health roadmaps include engaging lessons and skill-building techniques designed to empower individuals. The Companyâs wholly owned subsidiary is Trellus Health Inc.
Sector
Software
Calendar
2024-06-14
- Annual General Meeting
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -49.23% | 3.39M | |
| +14.39% | 3,174B | |
| +14.08% | 89.44B | |
| +8.04% | 80.2B | |
| -12.11% | 55.78B | |
| +22.36% | 46.14B | |
| -29.01% | 45.34B | |
| +31.67% | 45.25B | |
| +77.73% | 41.2B | |
| -3.95% | 26.11B |
- Stock Market
- Equities
- TRLS Stock
